Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Filling AAV capsids: estimating success by cryo-EM.

Subramanian S, Maurer A, Bator C, Makhov A, Conway J, Turner KB, Marden J, Vandenberghe LH, Hafenstein S.

Hum Gene Ther. 2019 Sep 18. doi: 10.1089/hum.2019.041. [Epub ahead of print]

PMID:
31530236
2.

Sequence Tolerance of a Single-Domain Antibody with a High Thermal Stability: Comparison of Computational and Experimental Fitness Profiles.

Olson MA, Legler PM, Zabetakis D, Turner KB, Anderson GP, Goldman ER.

ACS Omega. 2019 Jun 17;4(6):10444-10454. doi: 10.1021/acsomega.9b00730. eCollection 2019 Jun 30.

3.

Quantification of Interlaboratory Cell-Free Protein Synthesis Variability.

Cole SD, Beabout K, Turner KB, Smith ZK, Funk VL, Harbaugh SV, Liem AT, Roth PA, Geier BA, Emanuel PA, Walper SA, Chávez JL, Lux MW.

ACS Synth Biol. 2019 Sep 20;8(9):2080-2091. doi: 10.1021/acssynbio.9b00178. Epub 2019 Sep 10.

PMID:
31386355
4.

Bacterial bioreactors: Outer membrane vesicles for enzyme encapsulation.

Turner KB, Dean SN, Walper SA.

Methods Enzymol. 2019;617:187-216. doi: 10.1016/bs.mie.2018.12.012. Epub 2019 Jan 25.

PMID:
30784402
5.

Deamidation of Amino Acids on the Surface of Adeno-Associated Virus Capsids Leads to Charge Heterogeneity and Altered Vector Function.

Giles AR, Sims JJ, Turner KB, Govindasamy L, Alvira MR, Lock M, Wilson JM.

Mol Ther. 2018 Dec 5;26(12):2848-2862. doi: 10.1016/j.ymthe.2018.09.013. Epub 2018 Oct 18.

PMID:
30343890
6.

Environmental Decontamination of a Chemical Warfare Simulant Utilizing a Membrane Vesicle-Encapsulated Phosphotriesterase.

Alves NJ, Moore M, Johnson BJ, Dean SN, Turner KB, Medintz IL, Walper SA.

ACS Appl Mater Interfaces. 2018 May 9;10(18):15712-15719. doi: 10.1021/acsami.8b02717. Epub 2018 Apr 30.

PMID:
29672020
7.

Targeting and delivery of therapeutic enzymes.

Dean SN, Turner KB, Medintz IL, Walper SA.

Ther Deliv. 2017 Jul;8(7):577-595. doi: 10.4155/tde-2017-0020. Review.

PMID:
28633594
8.

Conjugation of biotin-coated luminescent quantum dots with single domain antibody-rhizavidin fusions.

Liu JL, Walper SA, Turner KB, Lee AB, Medintz IL, Susumu K, Oh E, Zabetakis D, Goldman ER, Anderson GP.

Biotechnol Rep (Amst). 2016 Mar 3;10:56-65. doi: 10.1016/j.btre.2016.03.001. eCollection 2016 Jun.

9.

Pairing Alpaca and Llama-Derived Single Domain Antibodies to Enhance Immunoassays for Ricin.

Turner KB, Hardy S, Liu JL, Zabetakis D, Lee PAB, Goldman ER, Anderson GP.

Antibodies (Basel). 2017 Feb 2;6(1). pii: E3. doi: 10.3390/antib6010003.

10.
11.

Affinity purification of bacterial outer membrane vesicles (OMVs) utilizing a His-tag mutant.

Alves NJ, Turner KB, DiVito KA, Daniele MA, Walper SA.

Res Microbiol. 2017 Feb - Mar;168(2):139-146. doi: 10.1016/j.resmic.2016.10.001. Epub 2016 Oct 20.

12.

Protecting enzymatic function through directed packaging into bacterial outer membrane vesicles.

Alves NJ, Turner KB, Medintz IL, Walper SA.

Sci Rep. 2016 Apr 27;6:24866. doi: 10.1038/srep24866.

13.

Next-Generation Sequencing of a Single Domain Antibody Repertoire Reveals Quality of Phage Display Selected Candidates.

Turner KB, Naciri J, Liu JL, Anderson GP, Goldman ER, Zabetakis D.

PLoS One. 2016 Feb 19;11(2):e0149393. doi: 10.1371/journal.pone.0149393. eCollection 2016.

14.

Improving the targeting of therapeutics with single-domain antibodies.

Turner KB, Alves NJ, Medintz IL, Walper SA.

Expert Opin Drug Deliv. 2016;13(4):561-70. doi: 10.1517/17425247.2016.1133583. Epub 2016 Jan 25. Review.

PMID:
26689649
15.

Optimizing Nanoplasmonic Biosensor Sensitivity with Orientated Single Domain Antibodies.

Raphael MP, Christodoulides JA, Byers JM, Anderson GP, Liu JL, Turner KB, Goldman ER, Delehanty JB.

Plasmonics. 2015;10(6):1649-1655. Epub 2015 May 26.

16.

Bacterial Nanobioreactors--Directing Enzyme Packaging into Bacterial Outer Membrane Vesicles.

Alves NJ, Turner KB, Daniele MA, Oh E, Medintz IL, Walper SA.

ACS Appl Mater Interfaces. 2015 Nov 11;7(44):24963-72. doi: 10.1021/acsami.5b08811. Epub 2015 Oct 29.

PMID:
26479678
17.

Enhanced production of a single domain antibody with an engineered stabilizing extra disulfide bond.

Liu JL, Goldman ER, Zabetakis D, Walper SA, Turner KB, Shriver-Lake LC, Anderson GP.

Microb Cell Fact. 2015 Oct 9;14:158. doi: 10.1186/s12934-015-0340-3.

18.

Can template-based protein models guide the design of sequence fitness for enhanced thermal stability of single domain antibodies?

Olson MA, Zabetakis D, Legler PM, Turner KB, Anderson GP, Goldman ER.

Protein Eng Des Sel. 2015 Oct;28(10):395-402. doi: 10.1093/protein/gzv047. Epub 2015 Sep 14.

PMID:
26374895
19.

Emerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesicles.

Alves NJ, Turner KB, Medintz IL, Walper SA.

Ther Deliv. 2015 Jul;6(7):873-87. doi: 10.4155/tde.15.40. Review.

20.

Enzymatic bioconjugation of nanoparticles: developing specificity and control.

Walper SA, Turner KB, Medintz IL.

Curr Opin Biotechnol. 2015 Aug;34:232-41. doi: 10.1016/j.copbio.2015.04.003. Epub 2015 May 2. Review.

PMID:
25955793
21.

Improving the biophysical properties of anti-ricin single-domain antibodies.

Turner KB, Liu JL, Zabetakis D, Lee AB, Anderson GP, Goldman ER.

Biotechnol Rep (Amst). 2015 Jan 15;6:27-35. doi: 10.1016/j.btre.2015.01.001. eCollection 2015 Jun.

22.

Isolation and epitope mapping of staphylococcal enterotoxin B single-domain antibodies.

Turner KB, Zabetakis D, Legler P, Goldman ER, Anderson GP.

Sensors (Basel). 2014 Jun 19;14(6):10846-63. doi: 10.3390/s140610846.

23.

Glucose recognition proteins for glucose sensing at physiological concentrations and temperatures.

Joel S, Turner KB, Daunert S.

ACS Chem Biol. 2014 Jul 18;9(7):1595-602. doi: 10.1021/cb500132g. Epub 2014 May 29.

24.

Enhanced stabilization of a stable single domain antibody for SEB toxin by random mutagenesis and stringent selection.

Turner KB, Zabetakis D, Goldman ER, Anderson GP.

Protein Eng Des Sel. 2014 Mar;27(3):89-95. doi: 10.1093/protein/gzu001. Epub 2014 Jan 30.

PMID:
24488977
25.

Negative tail fusions can improve ruggedness of single domain antibodies.

Goldman ER, Brozozog-Lee PA, Zabetakis D, Turner KB, Walper SA, Liu JL, Anderson GP.

Protein Expr Purif. 2014 Mar;95:226-32. doi: 10.1016/j.pep.2014.01.003. Epub 2014 Jan 15.

PMID:
24440507
26.

Thermostable single domain antibody-maltose binding protein fusion for Bacillus anthracis spore protein BclA detection.

Walper SA, Battle SR, Audrey Brozozog Lee P, Zabetakis D, Turner KB, Buckley PE, Calm AM, Welsh HS, Warner CR, Zacharko MA, Goldman ER, Anderson GP.

Anal Biochem. 2014 Feb 15;447:64-73. doi: 10.1016/j.ab.2013.10.031. Epub 2013 Oct 30.

PMID:
24184358
27.

Translation to practice of an intervention to promote colorectal cancer screening among African Americans.

Smith S, Johnson L, Wesley D, Turner KB, McCray G, Sheats J, Blumenthal D.

Clin Transl Sci. 2012 Oct;5(5):412-5. doi: 10.1111/j.1752-8062.2012.00439.x. Epub 2012 Aug 7.

28.

Accumulation and efflux of polychlorinated biphenyls in Escherichia coli.

Geng S, Fang J, Turner KB, Daunert S, Wei Y.

Anal Bioanal Chem. 2012 Jun;403(8):2403-9. doi: 10.1007/s00216-012-5835-8. Epub 2012 Feb 21.

PMID:
22349406
29.

Identification of binding specificity-determining features in protein families.

Anderson PC, De Sapio V, Turner KB, Elmer SP, Roe DC, Schoeniger JS.

J Med Chem. 2012 Mar 8;55(5):1926-39. doi: 10.1021/jm200979x. Epub 2012 Feb 17.

PMID:
22289061
30.

Prison outbreak: pandemic (H1N1) 2009 in an Australian prison.

Turner KB, Levy MH.

Public Health. 2010 Feb;124(2):119-21. doi: 10.1016/j.puhe.2009.12.005. Epub 2010 Feb 10. No abstract available.

PMID:
20149400
31.

SHAMS: combining chemical modification of RNA with mass spectrometry to examine polypurine tract-containing RNA/DNA hybrids.

Turner KB, Yi-Brunozzi HY, Brinson RG, Marino JP, Fabris D, Le Grice SF.

RNA. 2009 Aug;15(8):1605-13. doi: 10.1261/rna.1615409. Epub 2009 Jun 17.

32.

Probing anomalous structural features in polypurine tract-containing RNA-DNA hybrids with neomycin B.

Brinson RG, Turner KB, Yi-Brunozzi HY, Le Grice SF, Fabris D, Marino JP.

Biochemistry. 2009 Jul 28;48(29):6988-97. doi: 10.1021/bi900357j.

33.
34.

Like polarity ion/ion reactions enable the investigation of specific metal interactions in nucleic acids and their noncovalent assemblies.

Turner KB, Monti SA, Fabris D.

J Am Chem Soc. 2008 Oct 8;130(40):13353-63. doi: 10.1021/ja8045734. Epub 2008 Sep 12.

35.

Resistance to RevM10 inhibition reflects a conformational switch in the HIV-1 Rev response element.

Legiewicz M, Badorrek CS, Turner KB, Fabris D, Hamm TE, Rekosh D, Hammarskjöld ML, Le Grice SF.

Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14365-70. doi: 10.1073/pnas.0804461105. Epub 2008 Sep 5.

36.

Structural probing of the HIV-1 polypurine tract RNA:DNA hybrid using classic nucleic acid ligands.

Turner KB, Brinson RG, Yi-Brunozzi HY, Rausch JW, Miller JT, Le Grice SF, Marino JP, Fabris D.

Nucleic Acids Res. 2008 May;36(8):2799-810. doi: 10.1093/nar/gkn129. Epub 2008 Apr 9.

37.

Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy.

Stephen AG, Datta SA, Worthy KM, Bindu L, Fivash MJ, Turner KB, Fabris D, Rein A, Fisher RJ.

J Biomol Tech. 2007 Sep;18(4):259-66.

38.

End-stacking of copper cationic porphyrins on parallel-stranded guanine quadruplexes.

Evans SE, Mendez MA, Turner KB, Keating LR, Grimes RT, Melchoir S, Szalai VA.

J Biol Inorg Chem. 2007 Nov;12(8):1235-49. Epub 2007 Sep 5.

PMID:
17786488
39.

Understanding the isomerization of the HIV-1 dimerization initiation domain by the nucleocapsid protein.

Turner KB, Hagan NA, Fabris D.

J Mol Biol. 2007 Jun 8;369(3):812-28. Epub 2007 Mar 30.

40.

Mapping noncovalent ligand binding to stemloop domains of the HIV-1 packaging signal by tandem mass spectrometry.

Turner KB, Hagan NA, Kohlway AS, Fabris D.

J Am Soc Mass Spectrom. 2006 Oct;17(10):1402-1411. doi: 10.1016/j.jasms.2006.06.009. Epub 2006 Jul 26.

41.
42.

Identification of a novel non-carbohydrate molecule that binds to the ribosomal A-site RNA.

Maddaford SP, Motamed M, Turner KB, Choi MS, Ramnauth J, Rakhit S, Hudgins RR, Fabris D, Johnson PE.

Bioorg Med Chem Lett. 2004 Dec 20;14(24):5987-90.

PMID:
15546714
43.

cADPR analogues: effect of an adenosine 2'- or 3'-methoxy group on conformation.

Graham SM, Macaya DJ, Sengupta RN, Turner KB.

Org Lett. 2004 Jan 22;6(2):233-6.

PMID:
14723536
44.

The cholesterol-esterifying enzyme of human serum. I. In liver disease.

TURNER KB, McCORMACK GH Jr, RICHARDS A.

J Clin Invest. 1953 Sep;32(9):801-6. No abstract available.

45.

Student-patient relationships in outpatient teaching.

OPPENHEIMER RH, BAKST HJ, HARWOOD TH, BACHMEYER AC, TURNER KB.

J Med Educ. 1951 May;26(3 1):178-81. No abstract available.

PMID:
14824835
46.

Effect of incubation on the cholesterol partition in human serum.

TURNER KB, PRATT V.

Proc Soc Exp Biol Med. 1949 Aug;71(4):633-7. No abstract available.

PMID:
18139833
47.

OBSERVATIONS ON THE BLOOD IODINE. I. THE BLOOD IODINE IN HEALTH, IN THYROID AND CARDIORENAL DISEASE, AND IN LEUKEMIA.

Turner KB, Delamater A, Province WD.

J Clin Invest. 1940 May;19(3):515-24. No abstract available.

48.

OBSERVATIONS ON THE SERUM CHOLESTEROL IN ACUTE INFECTIONS AS RECORDED DURING AND AFTER PNEUMONIA.

Steiner A, Turner KB.

J Clin Invest. 1940 Mar;19(2):373-7. No abstract available.

49.

A LONG TERM STUDY OF THE VARIATION OF SERUM CHOLESTEROL IN MAN.

Turner KB, Steiner A.

J Clin Invest. 1939 Jan;18(1):45-9. No abstract available.

50.

THE ROLE OF THE THYROID IN THE REGULATION OF THE BLOOD CHOLESTEROL OF RABBITS.

Turner KB, Present CH, Bidwell EH.

J Exp Med. 1938 Jan 1;67(1):111-27.

Supplemental Content

Loading ...
Support Center